clinical pathways

Perspectives

Approaching Clinical Pathway Development as an Art

11/18/2020

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Abstract: In health care, rules and regulations are in place for good reason, but there is an art to integrating them into care effectively to benefit patients as well as the other stakeholders—clinically and...

...

11/18/2020

Journal of Clinical Pathways

Perspectives

Supporting Optimal, Value-Based, and Sustainable Cancer Care Delivery

10/21/2020

Anita Pudusseri , DO;

Paul J. Hesketh , MD;

Sylvia Richey , MD;

Lee Schwartzberg , MD, FACP;

Rebecca Stein ;

Wui-Jin Koh , MD;

Tyler Haydell ;

Corrine Zarwan , MD;

Barbara McAneny , MD;

Alison Fugaro , PA;

Edward Arrowsmith , MD;

Abstract: As the cancer care landscape continues to evolve, oncologists must stay up to date on the latest treatment options for their patients while also navigating the administrative complexities of running a...

...

10/21/2020

Journal of Clinical Pathways

From the Field

Developing Pathway to Cure: A Multimodal Clinical Pathway Platform to Support Timely and Appropriate Care of Women Under 50 Diagnosed With Breast Cancer

09/18/2020

Robin M. Lally , PhD, MS, RN, AOCN, FAAN;

Roksana Zak , PhD;

Allison F. Coates , BS, BSN, RN;

Elizabeth Reed , MD;

Ryan Ramaekers , MD;

Abstract: Pathway to Cure is a multimodal eHealth platform for oncology care providers and patients developed by a multidisciplinary team at the University of Nebraska Medical Center’s Fred & Pamela Buffett...

...

09/18/2020

Journal of Clinical Pathways

Interview

Elsevier’s ClinicalPath: Supporting Value-Based Care and the Path Forward

07/07/2020

In January 2018, Elsevier—an information analytics business specializing in science and health—acquired Via Oncology – a leading decision-support and clinical pathways vendor. Since that time, Elsevier has rebranded...

In...

07/07/2020

Journal of Clinical Pathways

Interview

Identifying and Addressing Multi-Stakeholder Gaps in Value Assessment

06/12/2020

While there is general consensus that existing value assessment methods are imperfect solutions for providing credible and relevant information on value specific to cancer care decisions, there is much less consensus...

While...

06/12/2020

Journal of Clinical Pathways

Interview

Prior Authorization for Comprehensive Genomic Profiling in Clinical Pathways

05/27/2020

At the Community Oncology Alliance (COA) Annual Meeting (April 24, 2020), Lee Schwartzberg, MD, FACP, West Cancer Center and Research Institute (a member of OneOncology), moderated a stakeholder panel discussion on...

At the...

05/27/2020

Journal of Clinical Pathways

News

Updates to ASCO’s Patient-Centered Oncology Payment Model

05/20/2020

An infographic published in JCO Oncology Practice (online May 12, 2020; doi:10.1200/OP.20.00179) highlights updates to the American Society of Clinical Oncology (ASCO) Patient-Centered Oncology Payment (PCOP)...

An...

05/20/2020

Journal of Clinical Pathways

Perspectives

The Challenge of Developing Pathways in a Rapidly Evolving Clinical Space: Chronic Lymphocytic Leukemia as a Case Study

03/16/2020

Ray Page , DO, PhD, FACOI, FASCO;

Andrew Hertler , MD, FACP;

Steve L. D'Amato , BSPharm, BCOP;

Michael Kolodziej , MD;

Barry Brooks , MD;

William A. Flood , MD, MS;

Abstract: Clinical pathways represent an effort to optimize value-based clinical decision making by standardizing (when appropriate) evidence-based care to offer patients the best outcome while remaining mindful of...

...

03/16/2020

Journal of Clinical Pathways

From the Field

The Supportive Care of Oncology Patients (SCOOP) Pathway: A Novel Approach to Improving the Patient Experience in the Curative Treatment of Cancer

05/15/2019

Nicholas Petrelli , MD, FACS;

Edith J. Johnson , PhD, MBA;

Christopher Koprowski , MD, MBA;

Karen Sites , MSN, RN, OCN, CCM;

Abstract: It was hypothesized that by introducing more intense supportive care and enhanced nurse navigation in high-acuity curable cancer patients, we could achieve the same results noted in patients with advanced...

...

05/15/2019

Journal of Clinical Pathways

Research Reports

Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting

02/15/2018

Michael A. Savin , MD;

Ravi Salgia , MD, PhD;

Blase Polite , MD;

Corey Shamah , MD;

Mark A. Socinski , MD;

Amanda Barry , MPH;

Kathy Lokay ;

Peter G. Ellis , MD;

Casey Mason ;

Ray Page , DO, PhD, FACOI, FASCO;

Natalie Dickson , MD;

Abstract: Despite clear clinical benefit and guideline recommendations for predictive biomarker testing and subsequent first-line targeted therapy treatment in patients with non–small cell lung cancer (NSCLC), there...

...

02/15/2018

Journal of Clinical Pathways